12.3 Rhabdomyolysis, Crush Injury & Polytrauma Damage Control Resuscitation

Rhabdomyolysis, Crush Injury & Polytrauma Damage Control Resuscitation

VTS Critical Concept: In massive polytrauma and crush injuries, patient survival is dictated not by immediate anatomic reconstruction, but by proactive physiologic resuscitation. Severe rhabdomyolysis releases lethal intracellular toxins (potassium, myoglobin) capable of inducing fatal cardiac arrest and anuric acute kidney injury. Concurrently, severe polytrauma triggers the Lethal Triad of Trauma (Hypothermia, Acidosis, and Coagulopathy), requiring modern Damage Control Resuscitation (DCR) strategies: permissive hypotension, early antifibrinolytic therapy (TXA), and balanced 1:1:1 component transfusion.

1. Rhabdomyolysis & Crush Injury Syndrome: Pathophysiology

Rhabdomyolysis is the rapid dissolution and necrosis of skeletal muscle fibers resulting in the release of intracellular myocyte contents into the systemic circulation. It occurs following massive blunt trauma, vehicular crush injury, entrapment/prolonged recumbency, severe exertional heatstroke, status epilepticus, or ischemic-reperfusion injury following arterial thromboembolism.

[ Pathophysiology of Crush Injury & Rhabdomyolysis ]
                         │
Direct Mechanical Compression + Ischemia-Reperfusion Insult
                         │
                         ▼
Depletion of Intracellular ATP & Failure of Na+/K+ & Ca2+ ATPases
                         │
                         ▼
Massive Influx of Extracellular Sodium (Na+) and Ionized Calcium (Ca2+)
                         │
                         ▼
Activation of Intracellular Proteases, Phospholipases & Endonucleases
                         │
                         ▼
Complete Sarcolemmal Rupture & Massive Release of Myocyte Contents
                         │
       ┌─────────────────┼────────────────────────┐
       ▼                 ▼                        ▼
[ Hyperkalemia ]   [ Hyperphosphatemia ]    [ Myoglobin & CK Surge ]
• K+ > 6.5-8.0 mEq/L • Drives acute hypocalcemia • CK > 10,000-100,000 U/L
• Fatal dysrhythmias • Metastatic calcification  • Pigment Nephropathy / AKI
• Sine wave / arrest                           • Lactic acidosis & shock

Systemic Toxic Cascades

2. Differential Diagnosis of Pigmenturia: Myoglobinuria vs. Hemoglobinuria vs. Hematuria

When a trauma patient presents with red, dark brown, or 'port wine' colored urine, the veterinary critical care technician must immediately execute a systematic 3-step diagnostic laboratory differentiation:

[ Diagnostic Differentiation of Red/Brown Urine ]
                        │
                        ▼
STEP 1: CENTRIFUGE URINE SAMPLE (1,500 rpm for 5 min)
                        │
       ┌────────────────┴────────────────────────┐
       ▼                                         ▼
[ Red Pellet at Bottom + Clear Supernatant ]  [ Supernatant Remains Dark Red/Brown ]
• DIAGNOSIS: HEMATURIA                        • DIAGNOSIS: PIGMENTURIA (Heme Present)
• Intact Red Blood Cells in Urine               (Proceed to Step 2: Blood Centrifugation)
• Hemorrhage from urinary tract / trauma
                        │
                        ▼
STEP 2: CENTRIFUGE ANTICOAGULATED BLOOD / HEMATOCRIT TUBE
                        │
       ┌────────────────┴────────────────────────┐
       ▼                                         ▼
[ Plasma / Serum is WATER-CLEAR ]             [ Plasma / Serum is PINK / RED (Hemolyzed) ]
• DIAGNOSIS: MYOGLOBINURIA                    • DIAGNOSIS: HEMOGLOBINURIA
• Myoglobin is small (17.8 kDa),                • Hemoglobin is large (64.5 kDa) and binds
  unbound to plasma proteins, and cleared         avidly to Haptoglobin. Once saturated,
  rapidly by kidneys into urine.                  free hemoglobin accumulates in plasma.
                        │
                        ▼
STEP 3: 80% AMMONIUM SULFATE PRECIPITATION TEST (Confirmatory)
• Add (NH4)2SO4 to urine: Hemoglobin precipitates out; Myoglobin remains in solution

Comparative Laboratory Characteristics

3. Prevention & Management of Myoglobinuric Acute Kidney Injury (AKI)

Pathogenesis of Myoglobin Nephrotoxicity

Myoglobin induces Acute Tubular Necrosis (ATN) through three synergistic pathophysiological mechanisms:

1. Renal Medullary Vasoconstriction: Free heme proteins scavenge endothelial nitric oxide (NO), causing severe intrarenal vasoconstriction, renal medullary ischemia, and a drastic decline in Glomerular Filtration Rate (GFR).
2. Intratubular Cast Precipitation: Under acidic urinary conditions ($pH < 5.6$), myoglobin dissociates into ferrihemate (hematin), which aggregates and precipitates with Tamm-Horsfall mucoprotein in the distal convoluted tubules, forming dense, occlusive tubular casts.
3. Direct Oxidant Cytotoxicity: The iron ($Fe^{2+}/Fe^{3+}$) in the heme ring catalyzes the generation of toxic hydroxyl free radicals via the Fenton reaction, inducing lipid peroxidation of proximal tubular cell membranes and cell death.

Nephroprotective Fluid Diuresis Protocols

• Aggressive Balanced Crystalloid Resuscitation: Initiate high-volume intravenous diuresis using balanced isotonic crystalloids (Plasmalyte-A, Normosol-R, or LRS) at $2-3\times\text{ maintenance}$ ($6-10\text{ mL/kg/hr}$) initially to expand intravascular volume, restore renal perfusion, and flush obstructing casts from the renal tubules.
• Target Urine Output (UOP): Place a closed indwelling Foley catheter to monitor hourly urine output. The mandatory therapeutic endpoint is $\text{UOP} > 2.0-3.0\text{ mL/kg/hr}$.
• Urinary Alkalinization Considerations: In severe myoglobinuria, administer Sodium Bicarbonate ($1-2\text{ mEq/kg}$ slow IV over $4-6\text{ hours}$) or add to IV fluids to maintain urine $pH > 6.5-7.0$. Alkalinization prevents the dissociation of myoglobin into toxic ferrihemate and inhibits cast precipitation. (Caution: Avoid over-alkalinization, which can worsen hypocalcemia and cause metabolic alkalosis).
• Emergency Treatment of Severe Hyperkalemia ($K^+ > 7.0\text{ mmol/L}$):
  • Myocardial Protection: 10% Calcium Gluconate ($0.5-1.0\text{ mL/kg}$ slow IV over $10\text{ min}$) under continuous ECG monitoring to restore normal cardiac membrane threshold potentials (does not lower serum potassium).
  • Intracellular Potassium Shifting: Regular Insulin ($0.25-0.5\text{ Units/kg}$ IV) accompanied immediately by a 50% Dextrose bolus ($1-2\text{ g per Unit of insulin}$ diluted $1:1$ with saline), followed by a continuous $2.5-5.0%$ dextrose infusion to prevent severe hypoglycemia.

4. Polytrauma & The Lethal Triad of Trauma

In severe polytrauma, mortality is driven by a self-propagating pathophysiological vortex known as the Lethal Triad of Trauma:

1. Hypothermia (Core Temperature $<95.0^\circ\text{F}\ /\ 35.0^\circ\text{C}$):
   • Caused by shock-induced hypoperfusion, exposure, and massive infusion of room-temperature fluids.
   • Directly impairs the enzymatic kinetics of the coagulation cascade; clotting factor activity drops by $10%$ for every $1.0^\circ\text{C}$ drop in body temperature.
   • Inhibits platelet activation, adhesion, and thromboxane $A_2$ synthesis.
2. Severe Metabolic Acidosis ($pH < 7.20$, Base Deficit $> -10\text{ mmol/L}$, Blood Lactate $>5.0\text{ mmol/L}$):
   • Results from profound systemic tissue hypoperfusion, cellular hypoxia, and anaerobic glycolysis.
   • Severely suppresses coagulation protease assembly: the enzymatic activity of the Factor VIIa/Tissue Factor complex decreases by $90%$ at $pH 7.0$.
   • Depresses myocardial contractility and induces refractory peripheral vasodilation.
3. Trauma-Induced Coagulopathy (TIC):
   • An acute endogenous impairment of hemostasis triggered within minutes of trauma by massive tissue injury, endothelial damage, activated protein C upregulation, and hyperfibrinolysis.
   • Severely exacerbated iatrogenically by crystalloid hemodilution (washing out clotting factors and platelets) and hypothermia.

5. Damage Control Resuscitation (DCR) & Damage Control Surgery (DCS)

Traditional resuscitation paradigms emphasizing massive crystalloid boluses ($60-90\text{ mL/kg}$) and immediate definitive 4-hour orthopedic/cavitary reconstructions have been replaced by Damage Control Resuscitation (DCR).

Modern Damage Control Pillars

[ The Four Pillars of Damage Control Resuscitation ]
                        │
       ┌────────────────┼────────────────────────┬────────────────────────┐
       ▼                ▼                        ▼                        ▼
[ Permissive      [ Early TXA              [ Balanced MTP           [ Damage Control
  Hypotension ]     Antifibrinolytic ]       1:1:1 Ratio ]            Surgery (DCS) ]
• Target MAP        • 10-20 mg/kg IV slow    • 1 pRBC : 1 FFP :       • Abbreviated surgery
  50-60 mmHg          over 15-20 min           1 Platelet unit          (< 60 minutes)
• Target SBP        • MUST give within       • Prevents dilutional    • Stop active bleeding
  80-90 mmHg          3 HOURS of trauma        coagulopathy             and contamination
• Avoids 'Popping   • Blocks plasminogen     • Serial ionized Ca2+    • Defer definitive
  the Clot'           activation               monitoring               repair to ICU phase

Detailed Resuscitation Principles

1. Permissive Hypotension (Hypotensive Resuscitation):

   • Principle: Restricting the rate and volume of intravenous crystalloids prior to surgical hemostasis.
   • Target Endpoints: Maintain a Mean Arterial Pressure (MAP) of $50-60\text{ mmHg}$ or a Systolic Blood Pressure (SBP) of $80-90\text{ mmHg}$ (palpable femoral pulse, clear mentation).
   • Physiological Rationale: Delivering large crystalloid boluses elevates intravascular hydrostatic pressure and dilutes coagulation factors, which dislodges newly formed hemostatic clots ('popping the clot') and accelerates fatal cavitary hemorrhage.
   • ABSOLUTE CONTRAINDICATION: Traumatic Brain Injury (TBI). In patients with concurrent TBI, permissive hypotension is strictly contraindicated; maintaining cerebral perfusion pressure requires keeping $MAP > 80\text{ mmHg}$ ($SBP > 100-110\text{ mmHg}$).

2. Early Tranexamic Acid (TXA) Administration:

   • Mechanism: TXA is a synthetic lysine analog that competitively binds to plasminogen, preventing its activation to plasmin and halting hyperfibrinolytic clot breakdown.
   • Dosage & Timing: Administer $10-20\text{ mg/kg}$ IV slow over $15-20\text{ minutes}$. Mandatory Timing Window: TXA must be administered within 3 hours of trauma onset. Administration $>3\text{ hours}$ post-injury paradoxically increases mortality by exacerbating microvascular thrombosis and inflammatory tissue injury.

3. Massive Transfusion Protocol (MTP) & Balanced Blood Ratios:

   • Indicated in catastrophic trauma hemorrhage (defined as loss of $>50%$ total blood volume within $3\text{ hours}$, or $>100%$ blood volume within $24\text{ hours}$).
   • 1:1:1 Balanced Ratio: Deliver equal ratios of Packed Red Blood Cells (pRBCs), Fresh Frozen Plasma (FFP), and Platelet Concentrates / Cryoprecipitate (e.g., $1\text{ unit pRBC} : 1\text{ unit FFP} : 1\text{ unit Platelets}$). Balanced component therapy prevents dilutional coagulopathy, severe thrombocytopenia, and hypofibrinogenemia.
   • Citrate Toxicity & Ionized Calcium: Blood products are preserved with citrate, which binds circulating ionized calcium. During massive transfusion, monitor $iCa^{2+}$ every 30-60 minutes; administer $10%$ Calcium Gluconate ($0.5\text{ mL/kg}$ slow IV) if $iCa^{2+} < 1.0\text{ mmol/L}$ to prevent myocardial depression and worsening coagulopathy.

4. Damage Control Surgery (DCS):

   • Abbreviated Surgical Time ($<60\text{ minutes}$): Rapid laparotomy/thoracotomy strictly limited to controlling active surgical hemorrhage (direct clamping, packing, vascular shunting) and controlling gastrointestinal contamination (rapid stapling/ligation without resection).
   • Temporary Abdominal Closure (TAC): Abdomen is packed and closed temporarily using vacuum-assisted closure (open peritoneal drainage).
   • ICU Resuscitation Phase: Patient is transferred immediately to the ICU for aggressive active rewarming, correction of severe metabolic acidosis, reversal of coagulopathy with FFP and platelets, and optimization of oxygen delivery.
   • Definitive Reconstruction: The patient returns to the OR $24-48\text{ hours}$ later for definitive organ reconstruction and fracture fixation once physiological homeostasis has been fully restored.